Loading clinical trials...
Loading clinical trials...
Open-label Safety Trial of Intravenous Neridronic Acid in Subjects With Complex Regional Pain Syndrome (CRPS)
Conditions
Interventions
Neridronic acid
Locations
46
United States
US017: Cactus Clinical Research, Inc.
Phoenix, Arizona, United States
US028: Quality of Life Medical and Research Centers LLC
Tucson, Arizona, United States
US045: Woodland International Research Group
Little Rock, Arkansas, United States
US044: Woodland Research Northwest
Rogers, Arkansas, United States
US012: Orange County Research Institute
Anaheim, California, United States
US022: Core Healthcare Group
Cerritos, California, United States
Start Date
December 20, 2016
Primary Completion Date
January 9, 2019
Completion Date
January 9, 2019
Last Updated
November 21, 2019
NCT07473635
NCT05777889
NCT05052736
NCT04144972
NCT06453447
NCT06393101
Lead Sponsor
Grünenthal GmbH
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions